JP2015043779A5 - - Google Patents

Download PDF

Info

Publication number
JP2015043779A5
JP2015043779A5 JP2014222204A JP2014222204A JP2015043779A5 JP 2015043779 A5 JP2015043779 A5 JP 2015043779A5 JP 2014222204 A JP2014222204 A JP 2014222204A JP 2014222204 A JP2014222204 A JP 2014222204A JP 2015043779 A5 JP2015043779 A5 JP 2015043779A5
Authority
JP
Japan
Prior art keywords
cell
endothelial cells
vcam
selectin
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014222204A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015043779A (ja
JP6325419B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015043779A publication Critical patent/JP2015043779A/ja
Publication of JP2015043779A5 publication Critical patent/JP2015043779A5/ja
Application granted granted Critical
Publication of JP6325419B2 publication Critical patent/JP6325419B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014222204A 2009-07-21 2014-10-31 白血球溢出を低下させる幹細胞の使用 Expired - Fee Related JP6325419B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22730909P 2009-07-21 2009-07-21
US61/227,309 2009-07-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012521750A Division JP6243119B2 (ja) 2009-07-21 2010-07-21 白血球溢出を低下させる幹細胞の使用

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2016082666A Division JP2016129523A (ja) 2009-07-21 2016-04-18 白血球溢出を低下させる幹細胞の使用
JP2018025725A Division JP2018086011A (ja) 2009-07-21 2018-02-16 白血球溢出を低下させる幹細胞の使用

Publications (3)

Publication Number Publication Date
JP2015043779A JP2015043779A (ja) 2015-03-12
JP2015043779A5 true JP2015043779A5 (enExample) 2015-11-19
JP6325419B2 JP6325419B2 (ja) 2018-05-16

Family

ID=43497499

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2012521750A Active JP6243119B2 (ja) 2009-07-21 2010-07-21 白血球溢出を低下させる幹細胞の使用
JP2014222204A Expired - Fee Related JP6325419B2 (ja) 2009-07-21 2014-10-31 白血球溢出を低下させる幹細胞の使用
JP2016082666A Pending JP2016129523A (ja) 2009-07-21 2016-04-18 白血球溢出を低下させる幹細胞の使用
JP2018025725A Withdrawn JP2018086011A (ja) 2009-07-21 2018-02-16 白血球溢出を低下させる幹細胞の使用
JP2019199927A Withdrawn JP2020028298A (ja) 2009-07-21 2019-11-01 白血球溢出を低下させる幹細胞の使用
JP2021139876A Withdrawn JP2021182941A (ja) 2009-07-21 2021-08-30 白血球溢出を低下させる幹細胞の使用
JP2023087113A Pending JP2023099831A (ja) 2009-07-21 2023-05-26 白血球溢出を低下させる幹細胞の使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012521750A Active JP6243119B2 (ja) 2009-07-21 2010-07-21 白血球溢出を低下させる幹細胞の使用

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2016082666A Pending JP2016129523A (ja) 2009-07-21 2016-04-18 白血球溢出を低下させる幹細胞の使用
JP2018025725A Withdrawn JP2018086011A (ja) 2009-07-21 2018-02-16 白血球溢出を低下させる幹細胞の使用
JP2019199927A Withdrawn JP2020028298A (ja) 2009-07-21 2019-11-01 白血球溢出を低下させる幹細胞の使用
JP2021139876A Withdrawn JP2021182941A (ja) 2009-07-21 2021-08-30 白血球溢出を低下させる幹細胞の使用
JP2023087113A Pending JP2023099831A (ja) 2009-07-21 2023-05-26 白血球溢出を低下させる幹細胞の使用

Country Status (12)

Country Link
US (2) US20110020293A1 (enExample)
EP (2) EP3831930A1 (enExample)
JP (7) JP6243119B2 (enExample)
KR (2) KR20180014224A (enExample)
CN (2) CN102625829B (enExample)
AU (1) AU2010276201B2 (enExample)
BR (1) BR112012001329B1 (enExample)
CA (1) CA2768576C (enExample)
DK (1) DK2456853T3 (enExample)
IL (1) IL217648B (enExample)
SG (3) SG10201404280XA (enExample)
WO (1) WO2011011500A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009205886B2 (en) 2008-01-18 2015-08-27 Katholieke Universiteit Leuven Stem cell aggregates and methods for making and using
US20130129686A1 (en) * 2009-11-19 2013-05-23 Regents Of The University Reducing Inflammation Using Cell Therapy
SG183498A1 (en) * 2010-02-25 2012-09-27 Abt Holding Co Modulation of angiogenesis
WO2011106476A1 (en) * 2010-02-25 2011-09-01 Abt Holding Company Modulation of microglia activation
SG185526A1 (en) 2010-05-12 2012-12-28 Abt Holding Co Modulation of splenocytes in cell therapy
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
PL2718416T3 (pl) * 2011-06-06 2020-05-18 ReGenesys BVBA Namnażanie komórek macierzystych w bioreaktorach włóknisto-kapilarnych
US9901625B2 (en) 2011-10-15 2018-02-27 University Of Maryland, College Park Methods of regulating uptake and transcellular transport of leukocytes and therapeutics
WO2013123084A1 (en) * 2012-02-13 2013-08-22 Minerva Biotechnologies Corporation Method for detecting circulating fetal cells
IL289870B2 (en) 2013-04-12 2023-03-01 Lafrancesca Saverio Improving organs for transplantation
CA2986702C (en) 2015-05-21 2023-04-04 David Wang Modified demineralized cortical bone fibers
JP6757981B2 (ja) * 2015-07-02 2020-09-23 ナンヤン テクノロジカル ユニヴァーシティー 微少流体を用いる白血球および微小粒子分画
NZ745530A (en) 2016-01-21 2023-03-31 Abt Holding Co Stem cells for wound healing
AU2018261637A1 (en) * 2017-05-03 2019-12-12 Biomarin Pharmaceutical Inc. Improved lentiviruses for transduction of hematopoietic stem cells.
WO2021194272A1 (ko) * 2020-03-25 2021-09-30 울산과학기술원 질환 상태의 백혈구를 검출하거나, 백혈구 관련 질환을 진단하는 장치 또는 방법
US20230221303A1 (en) * 2020-04-20 2023-07-13 Longeveron Inc. Potency assay

Family Cites Families (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US5192553A (en) 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
JPH04500909A (ja) 1988-09-21 1992-02-20 アニマル バイオテクノロジー ケンブリッジ リミティド 家畜からの多能性胚細胞系の誘導
US7037721B1 (en) 1990-01-29 2006-05-02 Hy-Gene Biomedical, Inc. Protein-free defined media for the growth of normal human keratinocytes
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5635387A (en) 1990-04-23 1997-06-03 Cellpro, Inc. Methods and device for culturing human hematopoietic cells and their precursors
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
GB2254289B (en) 1991-04-05 1995-03-22 Gerber Garment Technology Inc Readily transferrable adherent tape and methods of use and making
US5851832A (en) 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
AU2882992A (en) 1991-11-06 1993-06-07 Arthur A. Axelrad Cell culture medium
US5460964A (en) 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
US5340740A (en) 1992-05-15 1994-08-23 North Carolina State University Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process
AU4543193A (en) * 1992-06-22 1994-01-24 Henry E. Young Scar inhibitory factor and use thereof
US5849553A (en) 1992-07-27 1998-12-15 California Institute Of Technology Mammalian multipotent neural stem cells
US5564183A (en) 1992-09-30 1996-10-15 Matsushita Electric Industrial Co., Ltd. Producing system of printed circuit board and method therefor
US5453357A (en) 1992-10-08 1995-09-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US7153684B1 (en) 1992-10-08 2006-12-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US5766951A (en) 1992-11-12 1998-06-16 Quality Biological, Inc. Serum-free medium supporting growth and proliferation of normal bone marrow cells
US5766948A (en) 1993-01-06 1998-06-16 The Regents Of The University Of California Method for production of neuroblasts
US6037174A (en) 1993-08-23 2000-03-14 Nexell Therapeutics, Inc. Preparation of serum-free suspensions of human hematopoietic cells or precursor cells
US5409813A (en) 1993-09-30 1995-04-25 Systemix, Inc. Method for mammalian cell separation from a mixture of cell populations
US6432711B1 (en) 1993-11-03 2002-08-13 Diacrin, Inc. Embryonic stem cells capable of differentiating into desired cell lines
FR2726003B1 (fr) 1994-10-21 2002-10-18 Agronomique Inst Nat Rech Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires
US5677136A (en) 1994-11-14 1997-10-14 Systemix, Inc. Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
US5914268A (en) 1994-11-21 1999-06-22 National Jewish Center For Immunology & Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5874301A (en) 1994-11-21 1999-02-23 National Jewish Center For Immunology And Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
GB9502022D0 (en) * 1995-02-02 1995-03-22 Abuljadayel Ilham M S A method for preparing lymphohaematopoietic progenitor cells
US5906934A (en) * 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
US6653134B2 (en) * 1995-03-28 2003-11-25 Cp Hahnemann University Isolated stromal cells for use in the treatment of diseases of the central nervous system
US5837670A (en) 1995-04-18 1998-11-17 Hartshorn; Richard Timothy Detergent compositions having suds suppressing properties
US5908782A (en) 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
US6015554A (en) 1995-06-07 2000-01-18 Systemix, Inc. Method of reconstituting human lymphoid and dendritic cells
WO1997032889A1 (en) * 1996-03-08 1997-09-12 The Regents Of The University Of Michigan MURINE α(1,3)FUCOSYLTRANSFERASE Fuc-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID
US6190910B1 (en) 1996-05-21 2001-02-20 The Institute Of Physical And Chemical Research Mouse embryonic stem cell lines
US5753506A (en) 1996-05-23 1998-05-19 Cns Stem Cell Technology, Inc. Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals
US5827740A (en) 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
US5945337A (en) 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
US6361996B1 (en) 1997-05-07 2002-03-26 University Of Utah Research Foundation Neuroepithelial stem cells and glial-restricted intermediate precursors
WO1998059035A2 (en) 1997-06-25 1998-12-30 The Goverment Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services, National Institutes Of Health Serum-free cell growth medium
JP4371179B2 (ja) 1997-07-04 2009-11-25 ユニバーシティー オブ ユタ リサーチ ファンデーション 系列限定ニューロン前駆体
US6387369B1 (en) * 1997-07-14 2002-05-14 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
US5968829A (en) 1997-09-05 1999-10-19 Cytotherapeutics, Inc. Human CNS neural stem cells
US6368636B1 (en) * 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US6328960B1 (en) * 1998-03-18 2001-12-11 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
PT1066060E (pt) * 1998-04-03 2003-12-31 Osiris Therapeutics Inc Celulas estaminais mesenquimais como imunossupressores
US6541247B1 (en) * 1998-06-25 2003-04-01 Neuronova Ab Method of isolating ependymal neural stem cells
SE9802264D0 (sv) * 1998-06-25 1998-06-25 Neuronova Ab A method of isolating cells
US6875607B1 (en) 1998-11-09 2005-04-05 Es Cell International Pte Ltd Embryonic stem cells
CA2348687A1 (en) 1998-11-09 2000-05-18 Consorzio Per La Gestione Del Centro Di Biotecnologie Avanzate Serum free medium for chondrocyte-like cells
WO2000029001A1 (en) * 1998-11-13 2000-05-25 Osiris Therapeutics, Inc. Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation
US6777231B1 (en) * 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20050153442A1 (en) 1999-03-10 2005-07-14 Adam Katz Adipose-derived stem cells and lattices
US20050169896A1 (en) * 1999-05-14 2005-08-04 Henry Ford Health System Bone marrow transplantation for treatment of stroke
WO2002064748A2 (en) 2001-02-14 2002-08-22 Furcht Leo T Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US7015037B1 (en) 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
US8147824B2 (en) * 1999-08-05 2012-04-03 Athersys, Inc. Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
US8075881B2 (en) * 1999-08-05 2011-12-13 Regents Of The University Of Minnesota Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
WO2001021767A2 (en) * 1999-09-24 2001-03-29 Morphogen Pharmaceuticals, Inc. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
NZ518601A (en) * 1999-09-24 2004-10-29 Morphogen Pharmaceuticals Inc Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
US20030161817A1 (en) * 2001-03-28 2003-08-28 Young Henry E. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
US6685936B2 (en) * 1999-10-12 2004-02-03 Osiris Therapeutics, Inc. Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation
CA2392615A1 (en) * 1999-12-06 2001-06-07 The General Hospital Corporation Pancreatic stem cells and their use in transplantation
US7582292B2 (en) * 2000-02-26 2009-09-01 Artecel, Inc. Adipose tissue derived stromal cells for the treatment of neurological disorders
EP1261694B1 (en) * 2000-02-26 2008-01-16 Artecel, Inc. Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
EP2298867A3 (en) 2000-06-20 2013-01-16 ES Cell International Pte Ltd. Method of controlling differentiation of embryonic stem (ES) cells by culturing ES cells in the presence of bmp-2 pathway antagonists
US20020061587A1 (en) * 2000-07-31 2002-05-23 Piero Anversa Methods and compositions for the repair and/or regeneration of damaged myocardium
AU2001296705A1 (en) * 2000-10-06 2002-04-15 The Regents Of The University Of California Blocking inflammation by inhibiting sialylation
US7560280B2 (en) 2000-11-03 2009-07-14 Kourion Therapeutics Gmbh Human cord blood derived unrestricted somatic stem cells (USSC)
DK1349918T3 (da) * 2000-12-06 2014-11-10 Anthrogenesis Corp Fremgangsmåde til indsamling af stamceller fra moderkagen
US7311905B2 (en) * 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
EP2316919B1 (en) * 2001-02-14 2015-10-07 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
US7056738B2 (en) * 2001-03-23 2006-06-06 Tulane University Early stage multipotential stem cells in colonies of bone marrow stromal cells
KR100449141B1 (ko) * 2001-04-19 2004-09-21 (주)라이프코드 간엽 간세포를 신경세포로 분화시키는 방법
US20030003090A1 (en) * 2001-05-31 2003-01-02 Prockop Darwin J. Directed in vitro differentiation of marrow stromal cells into neural cell progenitors
EP1421181A1 (en) 2001-08-23 2004-05-26 Reliance Life Sciences Pvt., Ltd. ISOLATION OF INNER CELL MASS FOR THE ESTABLISHMENT OF HUMAN EMBRYONIC STEM CELL (hESC) LINES
US9969980B2 (en) 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
US6703279B2 (en) 2002-01-04 2004-03-09 Promos Technologies, Inc. Semiconductor device having contact of Si-Ge combined with cobalt silicide
EP1478734A4 (en) 2002-01-25 2006-04-05 Genzyme Corp NON-SERUM MEDIUM FOR CHONDROCYTES AND METHODS OF USE THEREOF
US7145057B2 (en) 2002-02-01 2006-12-05 Origen Therapeutics, Inc. Chimeric bird from embryonic stem cells
AU2003230695A1 (en) 2002-03-20 2003-10-08 Sara Griffin Sports training device
US6962940B2 (en) * 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
GB0221481D0 (en) 2002-09-16 2002-10-23 Richards John M Grip for hand held instruments
AU2003298775B2 (en) * 2002-11-26 2008-07-17 Anthrogenesis Corporation Cytotherapeutics, cytotherapeutic units and methods for treatments using them
US7785601B2 (en) * 2002-12-31 2010-08-31 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors
WO2004069172A2 (en) * 2003-01-30 2004-08-19 The Government of the United States of America as represented by the Department of Veterans Affairs Multilineage-inducible cells and uses thereof
US20040235165A1 (en) * 2003-05-19 2004-11-25 Darwin Prockop In vitro differentiation of adult stem cells
EP1629089A1 (en) * 2003-06-03 2006-03-01 Organ Recovery Systems, Inc. Selection and propagation of progenitor cells
US20060210544A1 (en) * 2003-06-27 2006-09-21 Renomedix Institute, Inc. Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient
WO2005041944A2 (en) * 2003-06-27 2005-05-12 Schepens Eye Research Institute Methods and compositions for promoting axon regeneration and cell replacement therapy
WO2005001080A2 (en) * 2003-06-27 2005-01-06 Ethicon, Incorporated Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
EP2133362B1 (en) * 2003-07-25 2012-04-18 Amgen, Inc Methods relating to LDCAM and CRTAM
ITRM20030376A1 (it) * 2003-07-31 2005-02-01 Univ Roma Procedimento per l'isolamento e l'espansione di cellule staminali cardiache da biopsia.
AU2004269409A1 (en) * 2003-08-29 2005-03-10 Regents Of The University Of Minnesota Kidney derived stem cells and methods for their isolation, differentiation and use
WO2005025502A2 (en) * 2003-09-08 2005-03-24 Yeda Research And Development Co. Ltd. A method for treating or inhibiting the effects of injuries or diseases that result in neuronal degeneration
US8124072B2 (en) * 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
US9403908B2 (en) * 2003-09-29 2016-08-02 The Regents Of The University Of California Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration
US20050089513A1 (en) * 2003-10-28 2005-04-28 Norio Sakuragawa Side population cells originated from human amnion and their uses
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
EP3461884B1 (en) * 2004-03-22 2025-05-28 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
US7622108B2 (en) * 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
US8309070B2 (en) * 2004-05-17 2012-11-13 Regents Of The University Of Minnesota Use of umbilical cord blood stem cells to treat ischemic event
CN104027359A (zh) * 2006-01-23 2014-09-10 阿特西斯公司 无附加的免疫抑制治疗的mapc治疗法
NZ570614A (en) * 2006-01-23 2012-07-27 Athersys Inc Multipotent adult progenitor cell treatment of brain injuries and diseases
US20080194637A1 (en) * 2006-11-02 2008-08-14 Curis, Inc. Small organic molecule regulators of cell proliferation
US20100287638A1 (en) * 2007-10-01 2010-11-11 The Hospital For Sick Children Neural tumor stem cells and methods of use thereof
US20090130092A1 (en) * 2007-10-30 2009-05-21 Pinsky David J Nucleotide phosphate dissipation as a treatment for vascular disorders

Similar Documents

Publication Publication Date Title
JP2015043779A5 (enExample)
Feng et al. Stability and convergence of a new finite volume method for a two-sided space-fractional diffusion equation
Blatt Two primary configurations of psychopathology.
CY1123142T1 (el) Βελτιωμενες μεθοδοι για την παραγωγη θετων κυτταρικων θεραπειων
JP2019515674A5 (enExample)
JP2018027099A5 (enExample)
MY197695A (en) Anti-pd-1 antibody and use thereof
MX2017004890A (es) Metodos y composiciones para la generación o el mantenimiento de células pluripotentes.
WO2014201015A3 (en) Methods and compositions for target dna modification
MX2016007541A (es) Moléculas modificadas de ácido nucleico y usos de las mismas.
MX345730B (es) Células adherentes derivadas del amnios (amdac) para usarse en el tratamiento de enfermedades y trastornos relacionados con el sistema inmunitario.
CL2017000127A1 (es) Transacciones sintéticas entre puntos extremos de comunicación
WO2015200717A3 (en) Pcr-activated sorting (pas)
WO2016057961A8 (en) Compositions and methods for promoting homology directed repair
WO2011119507A3 (en) Method of altering the differentiative state of a cell and compositions thereof
WO2015073625A3 (en) Synergistic genome-nonintegrating reprogramming by micrornas and transcription factors
WO2014122035A3 (en) Induced dendritic cells and uses thereof
PH12017501218A1 (en) Rpe cell populations and methods of generating same
JP2016539641A5 (enExample)
Huillet et al. On the extended Moran model and its relation to coalescents with multiple collisions
EP4692350A3 (en) Compositions and methods for induced tissue regeneration in mammalian species
MX2017008338A (es) Metodos de cultivo de una celula de mamifero.
WO2017100313A8 (en) Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cells
Edlow et al. The pathway not taken: understanding ‘omics data in the perinatal context
Birkner et al. Importance sampling for Lambda-coalescents in the infinitely many sites model